Sep 16, 2012 - ... Horne1, Keith J Petrie2, Fiona M McQueen3 and William J Taylor4 ..... Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF: ...
Dalbeth et al. BMC Musculoskeletal Disorders 2012, 13:174 http://www.biomedcentral.com/1471-2474/13/174
RESEARCH ARTICLE
Open Access
Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout Nicola Dalbeth1*, Meaghan E House1, Anne Horne1, Keith J Petrie2, Fiona M McQueen3 and William J Taylor4
Abstract Background: Long term serum urate (SU) lowering to a target of